Preventing cervical cancer.
The Pap smear has been the classic screening strategy for preventing cervical cancer for 50 years. The finding that infection with human papillomavirus is associated with an increased risk of cervical cancer has prompted the development of new strategies for cervical cancer screening and prevention. In their Policy Forum, Cain and Howett discuss the introduction of HPV testing, anti-HPV microbicidal agents and vaccination against HPV. They point out the benefits but also the potential for over and under treatment and the need for considerable improvements in public education.
Cain
J M
JM
Departments of Obstetrics and Gynecology, The Pennsylvania State University, College of Medicine MB103 HOSPITAL, Hershey, PA 17033, USA.jcain@psghs.edu
Howett
M K
MK
D000998:Antiviral Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D008403:Mass Screening; D027383:Papillomaviridae / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity; D030361:Papillomavirus Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D014412:Tumor Virus Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000517:prevention & control* / Q000821:virology*; D014765:Viral Vaccines
D000998:Antiviral Agents; D014765:Viral Vaccines